Final Results Of CA209-9JC: A Phase 2 Study Of First-Line Nivolumab In Patients With Advanced Cutaneous Squamous Cell Carcinoma
Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Final Results Of CA209-9JC: A Phase 2 Study Of First-Line Nivolumab In Patients With Advanced Cutaneous Squamous Cell Carcinoma ### Output: Nivolumab